Checking a symptom questionnaire for teenagers with vestibular migraine
Tests a questionnaire that measures vestibular migraine symptoms in adolescents.
Key facts
- Who runs it
- Boston Children's Hospital
- Where
- Needham, Waltham, and Weymouth, United StatesSee the 3 sites
- Trial code
- Registry title
- Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents
- Status
- Not yet recruiting
- People taking part
- 70 people, planned
- Starts
- Dec 2026
- Expected to end
- Jun 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI)
- Record updated
- 22 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 10-20 with vestibular migraine of childhood, and also young people of the same age with no history of dizziness or migraines as a comparison group.
- Age
- 10 to 20 years
- Sex
- All sexes can join.
- Disease stage
- Patients must meet the 2021 Bárány Society criteria for definite or probable vestibular migraine of childhood. The comparison group has no history of dizziness and/or migraines.
Main reasons for not taking part
- Patients who do not meet the 2021 Bárány Society criteria for definite or probable vestibular migraine of childhood
- Comparison group: a history of dizziness and/or migraines
- Patients whose preferred language is not English
The registry criteria, word for word
Show all 9 criteriaShow less
Other criteria
- Experimental Patient Inclusion Criteria:
- Patients aged 10-20 years old
- Patients meeting the 2021 Bárány Society criteria for definite vestibular migraine of childhood (dVMC) or probable vestibular migraine of childhood (pVMC); Experimental Patient Exclusion Criteria:
- Patients who do not meet the 2021 Bárány Society criteria for definite vestibular migraine of childhood (dVMC) or probable vestibular migraine of childhood (pVMC)
- Non-English language preference patients; Control Patient Inclusion Criteria:
- Patients aged 10-20 years old
- Patients who do not have a history of dizziness and/or migraines; Control Patient Exclusion Criteria:
- Patients who have a history of dizziness and/or migraines
- Non-English language preference patients
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 20 years old?
Where in United States
- Boston Children's Hospital at NeedhamNeedham, United StatesContact: Jacob R Brodsky, MDNot yet recruiting
- Boston Children's Hospital at WalthamWaltham, United StatesContact: Jacob R Brodsky, MDNot yet recruiting
- Boston Children's Hospital at WeymouthWeymouth, United StatesContact: Jacob R Brodsky, MDNot yet recruiting
About the trial
What the trial wants to find out
Vestibular migraine (VM) is the most common cause of episodic dizziness in children and adults. Dizziness, especially in conjunction with other migraine symptoms (headache, photophobia, phonophobia, etc.) can profoundly decrease quality of life, so effective treatment of VM is of utmost importance.
Read full original descriptionShow less
Unfortunately, there is sparse research on effective treatment methods for VM, and even less for vestibular migraine of childhood (VMC), for which diagnostic criteria was recently defined by the Bárány Society in 2021. Lifestyle changes are often a large part of the treatment plan, and pharmacological treatment is also common, but their efficacies in treating VMC are less than ideal. In truth, there is yet to be a "gold-standard" medication or other treatment method for VMC.
There is a dire need for structured research on the efficacy of different treatments, both lifestyle and pharmacological, in treating pediatric patients with vestibular migraine. However, in order to conduct this research, a validated inventory to objectively and reliably measure vestibular migraine symptoms in children is required. Existing validated measures often used to assess vestibular migraine in children, do not account for the wide array of other symptoms associated with pediatric vestibular migraine.
The Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) - pronounced "Vempathy" - is a symptom inventory designed by Dr. Jeffrey Sharon and colleagues specifically to assess VM in adults. His group also worked to estimate a minimal clinically important difference (MCID) for the VM-PATHI in adults, finding that a change in VM-PATHI score of 6 points or more likely demonstrates an authentic clinical change in patient condition.
This study aims to validate the VM-PATHI for adolescents with VM and estimate a MCID for the VM-PATHI in adolescent patients with vestibular migraine.
The 2 groups in the trial
- Adolescents with Vestibular Migraine of Childhood (Experimental)
Adolescents aged 10-20 years old who have received a diagnosis of Vestibular Migraine of Childhood (VMC) per the 2021 Barany Society and International Headache Society diagnostic criteria.
Treatment: Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI)
- Adolescents without Vestibular Migraine of Childhood (Control)
Adolescents aged 10-20 years old who do not have any history of dizziness and/or migraines.
Treatment: Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents
- Plain-language title
- Checking a symptom questionnaire for teenagers with vestibular migraineGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07532109, who can take part
- Record updated
- 22 October 2026